- Research
- Open access
- Published:
Percutaneous nephrolithotomy versus retrograde intrarenal surgery on mid-sized lower calyx stones– a systematic review of last decade
BMC Urology volume 25, Article number: 84 (2025)
Abstract
Background
To systematically assess the effectiveness and safety of retrograde intrarenal surgery (RIRS) versus percutaneous nephrolithotomy (PCNL) in treating lower pole stones.
Methods
PubMed, Ovid MEDLINE, Web of Science, Cochrane Central Register of Controlled Trials (CENTRAL), and EMBASE were researched to identify relevant studies up to May 2018. Based on keyword searches, we explored 1972 studies; following screening and eligibility evaluation, 414 studies were removed for various reasons, including 11 possibly relevant studies for this systematic review. A total of 1342 patient data were interpreted (PCNLn = 688; RIRS n = 654).
Results
The stone-free rate (SFR) in ten studies following the PCNL operation varies from 68 to 98.3%, while after the RIRS procedure, it ranges from around 46–93.7%. Out of 10 investigations, 7 demonstrated a superior SFR for the PCNL technique compared to the RIRS. Of the ten investigations, eight demonstrated reduced surgical durations using the PCNL method compared to the RIRS procedure. The duration of hospital stays for the PCNL treatment varies from around 0.3 ± 0.04 to 5.3 ± 1.20 days, while the duration for RIRS procedures ranges from 0 to 3.2 ± 0.52 days. All nine trials indicated a reduced period of hospital stay with the RIRS technique compared to the PCNL procedure. The complication rates in 10 studies following the PCNL surgery varied from approximately 2–72%, while those after the RIRS procedure ranged from about 4–21.6%. Out of 10 trials, 6 demonstrated a reduced complication rate with the RIRS technique compared to the PCNL.
Conclusion
The majority of studies in this systematic review indicate that the PCNL method exhibits a superior SFR, reduced operational duration, prolonged hospital stay, and increased complication rates compared to the RIRS procedure.
Clinical trial number
Not applicable, as this is a systematic review.
Introduction
In recent years, the incidence of urinary system stone disease has been increasing due to reasons such as the increase in the elderly population, increasing obesity rate, poor eating habits, inadequate fluid intake, and sedentary lifestyle [1]. With increasing incidence, stone surgery continues to develop with operation techniques and technological advances. Technological advances in the last 30 years have revolutionized the treatment of urinary system stone disease. In the past, urinary system stone diseases were treated with open surgery. In the following years, percutaneous nephrolithotomy (PCNL) and shock wave lithotripsy (SWL) treatments took their place on the agenda. The frequency of retrograde intrarenal surgery (RIRS) has increased thanks to technological advances [2]. When the European Urology Guide is reviewed, one can see that PCNL is preferred in treating kidney stones 2 cm and larger. Smaller stones may be treated by external shockwave lithotripsy or RIRS despite suboptimal results for stones between 15 and 20 mm. Treatment for stones smaller than 2 cm is decided according to the stone’s location and the calyx’s structure, as well as the stone’s hardness and the patient’s expectations [3]. Developments in subheadings such as patient position, access techniques, mini percutaneous methods, PCNL-RIRS combination, and 3-dimensional demonstration of the stone can help us predict the future [2, 3].
Prior meta-analyses have evaluated the results of the two procedural methods, concluding that PCNL produces better surgical outcomes than RIRS. Nonetheless, their findings about postoperative complications and associated factors are contradictory. Due to the limitations in quality and sample size of the studies covered, previous study results require confirmation through prospective large-scale studies. In recent years, numerous well-structured Randomized Controlled Trials (RCTs) on this topic have been published, yet a consensus on the conclusions remains elusive [4].
Consequently, we intended to integrate and analyze the latest papers to establish data about the comparative efficacy and safety of PCNL and RIRS procedures for treating lower-pole renal stones (LPS). This initiative supports clinical decision-making by elaborating insights on stone-free rate (SFR), operative time, hospital stay, and overall complications.
Method
A systematic literature search was conducted on PubMed, SCOPUS, COCHRANE Central Register of Controlled Trials, and EMBASE to identify original peer-reviewed articles until December 2024. The criteria of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and the European Association of Urology (EAU) recommendations were followed. Retrograde intrarenal surgery and PCNL were assessed for comparative analysis. The principal endpoint was the SFR. Fig. 1 denotes the search approach and qualifying criteria for the systematic meta-analysis.
Literature search
The search utilized the following algorithm: ‘PCNL,’ ‘flexible ureteroscopy,’ ‘FURS,’ ‘retrograde intra-renal surgery,’ or ‘RIRS.’ The evidence level (LE) of each included trial was assessed based on the standards established by the European Association of Urology (EAU) Guidelines, and upon consensus regarding the final set of articles, two physicians (N.A, M.D) independently evaluated the quality of each article utilizing the Downs and Black checklist, which rated the quality of both randomized and nonrandomized trials. Additionally, those two writers reviewed the titles and abstracts of citations and acquired the complete texts of possibly eligible studies and any discrepancies. The reference lists of obtained papers were further examined for further qualifying publications.
A total of 1972 publications reviewed, published between 2001 and December 2024, met the eligibility criteria. The study included subjects with lower pole stones treated with RIRS or PCNL. Two corresponding authors responded to our inquiries to provide supplementary information.
Eligibility criteria
The inclusion criteria for the studies selected for the final analysis were as follows: [1] Language restricted to English; [2] Lower calyx renal stones around 1–3 cm measured by CT-Scan examination; [3] Patients who underwent PCNL or RIRS procedure; [4] Comparative studies must report at least one of the following outcomes for both PCNL and RIRS: SFR, operative time, length of hospital stay, and overall complications. Studies on [1] pediatric patients aged less than 18 years and [2] studies disseminated as conference abstracts or posters were excluded.
Data extraction and outcomes
The following information was recorded regarding each eligible study: author’s name, journal of publication, year of publication, country of origin, study type, total number of patients, and patient demographics. One initial search yielded 1972 studies, but only eleven were included in the final analysis based on eligibility criteria. The study’s flowchart is shown in Fig. 1.
Results
We explored 1972 studies based on keyword searches, following screening and eligibility evaluation, in the end, 11 relevant articles were selected for this systematic review [5,6,7,8,9,10,11,12,13,14,15]. Of the 11 possibly relevant research, 5 were prospective randomized controlled trials [5, 8,9,10,11], one was prospective [7], and five were retrospective analyses [6, 12,13,14,15]. All studies included were unblinded, with durations ranging from around seven months to five years and follow-up periods from one to twelve months. The investigations encompass patients with lower calyx renal stones measuring 1 to 3 cm as determined by a CT scan. In this comprehensive assessment of 1342 patients, 688 underwent PCNL surgery, while 654 underwent RIRS [5,6,7,8,9,10,11,12,13,14,15] (Table 1).
Clinical outcomes
Participants with lower pole calyx stones measuring 1.0–3.0 cm underwent PCNL (n = 688) and RIRS (n = 654) procedures. The SFR, operation time, length of hospital stay, and complications were evaluated (Table 2).
Stone-free rate
Out of 11 trials, 10 indicated SFRs after PCNL or RIRS treatments [5,6,7,8,9, 11,12,13,14,15]. A majority of the studies defined stone-free status as the absence of stones found by imaging scans following a median post-intervention follow-up of 4 months (Table 1). The SFR in ten studies following the PCNL operation varies from 68 to 98.3%, while after the RIRS procedure, it ranges from around 46–93.7%. Out of 10 investigations, 7 demonstrated a superior SFR for the PCNL technique compared to the RIRS [5, 6, 8, 9, 13,14,15]; conversely, two studies indicated a higher SFR for the RIRS procedure [11, 12], while 1 study reported comparable rates for both PCNL and RIRS procedures [7] (Table 2).
Duration of operation time
Ten of the eleven trials reported operative time after PCNL or RIRS procedures. The operation duration of the PCNL operation varies from approximately 46.2 ± 24.3 to 85.5 ± 41.1 min, while the operative duration of the RIRS technique ranges from approximately 55.8 ± 11.4 to 273 min [5,6,7,8,9,10, 12,13,14,15]. Of the ten investigations, eight demonstrated reduced surgical durations using the PCNL method compared to the RIRS procedure [5, 7,8,9, 11,12,13,14,15]. Nevertheless, using the RIRS method, we identified two studies indicating a reduced surgical duration [6, 10] (Table 2).
Duration of hospital stay
Nine of 11 trials indicated hospital admissions subsequent to PCNL or RIRS procedures. The duration of hospital stays for the PCNL treatment varies from around 0.3 ± 0.04 to 5.3 ± 1.20 days, while the duration for RIRS procedures ranges from 0 to 3.2 ± 0.52 days. All nine trials indicated a reduced period of hospital stay with the RIRS technique in comparison to the PCNL procedure [5,6,7,8, 10, 12,13,14,15].
Complication rates
Of the 11 trials, 10 reported problems following PCNL or RIRS treatments. Most studies categorized problems as any intra-operative and post-operative minor and major complications, with some employing the Clavien-Dindo classification for grading complications. The complication rates in 10 studies following the PCNL surgery varied from approximately 2–72%, while those after the RIRS procedure ranged from about 4–21.6% [5,6,7,8,9,10, 12,13,14,15]. Out of 10 trials, 6 demonstrated a reduced complication rate with the RIRS technique compared to the PCNL method [6,7,8, 12, 15]. Nevertheless, four studies indicated reduced complication rates associated with PCNL [5, 9, 10, 13, 14] (Table 2).
Discussion
The treatment of lower pole stones encompasses observation, RIRS, and PCNL. The decision between RIRS and PCNL often hinges on the patient’s circumstances. Our systematic analysis aimed to identify an improved protocol for individuals with renal stones in the lower pole calyx [16]. The findings of our investigation are consistent with prior systematic reviews and meta-analyses. Our study revealed that the PCNL treatment demonstrated a shorter operating duration compared to the RIRS method in certain instances. The RIRS procedure demonstrated a reduced hospital stay duration and a decreased complication rate compared to the PCNL operation. Our systematic review also indicated that PCNL and RIRS procedures are advantageous for patients; nevertheless, additional meta-analysis is required to derive more objective results and elucidate the benefits of these procedures. For clarity and ease of comparison, Fig. 2 provides a visual overview of how included studies distributed their conclusions between PCNL and RIRS across different clinical parameters.
As per the EAU, the first-line treatment option for calculi less than 2 cm is RIRS [17]. Recent advancements in RIRS technology have established it as a viable therapeutic alternative for bigger renal calculi. Although mPCNL exhibits a greater SFR, its complication rate parallels that of RIRS, albeit with a longer duration of inpatient hospitalization. A more extended inpatient stay is generally attributed to an indwelling nephrostomy tube for drainage and/or ongoing postoperative discomfort. Increased complications and extended hospitalizations will undoubtedly result in elevated expenses for supplementary laboratory testing, medical assessments, and heightened demands for analgesics and antibiotics [18].
Dutta et al. [5] conducted a prospective, randomized, controlled clinical trial using a 2-mm residual stone burden cutoff. MPCNL (n = 51) was more likely to render patients SFR than RIRS (n = 50). In contrast, Shabana et al. [6]. reported comparable duration of hospital stay, SFR, and complication rates between mPCNL and RIRS in treating 10–20 mm lower calyceal stones using propensity score matching analysis. The study of Zhang et al. [8] compared mPCNL, SWL, and RIRS on the treatment of 1–2 cm lower pole kidney stones. They elaborated that all techniques were safe and effective, but mPCNL and RIRS were more effective than SWL at a SFR. They also noted that mPCNL was more associated with complications, and the operation time was longer in RIRS [8]. Fayad et al. [9] stated that mPCNL had a better SFR than RIRS for managing lower calyceal stones of ⩽2 cm. Still, the hospital stay was more extended, and there were more intraoperative complications. RIRS had a significantly longer operating time than mPCNL, a higher incidence of postoperative fever, and a lower SFR. Armagan et al. [13]. and Koyuncu et al. [14]., and Kirac et al. [15] found comparable SFRs between mPCNL and RIRS in their retrospective analysis.
One of the RCTs analyzed in this systematic review was conducted by Dutta et al. [5] to compare ureteroscopy vs. prone mPCNL to treat lower real stones (1–2 cm). There was no difference in the number of postoperative complications that occurred within thirty days, the requirement for a secondary procedure within thirty days, or the change in creatinine levels from before to after the operation. The duration of the operation did not differ considerably. In the group that underwent mPCNL, the average length of stay was much longer. At the end of the study, they concluded that RIRS was less likely to result in patients being stone-free than mPCNL. The two techniques did not differ in the proportion of complications, surgery times, or operating margins [5].
In a randomized trial by Perri et al. [20]., they compared the outcomes of mPCNL and RIRS utilizing the SuperPulsed thulium fiber laser for treating 10 mm and 20 mm renal calculi. They stated that the SFRs were analogous between the two techniques. They noted that RIRS exhibited a statistically significant greater SFR, particularly for upper calyceal stones. The results indicate that RIRS with the SuperPulsed thulium fiber laser may provide a superior option to mPCNL, particularly for upper calyceal calculi [20]. In our review, we have also included the randomized study of Fayad et al. [9] that compared RIRS and PCNL. Their research indicated that RIRS and PCNL produced similar SFRs. Furthermore, they exhibited a clear benefit of RIRS by lowering the risk of hemorrhagic complications and decreasing the probability of transfusion necessity [9].
Unlike the studies included in this systematic review, Lv et al. [21]. investigated the removal of stones > 2 cm via RIRS and mPCNL. They sought to establish comparable groups by propensity score matching for a more dependable comparison. The study demonstrated that RIRS and mPCNL attained comparable SFRs, indicating that both techniques efficiently addressed kidney stones of this magnitude. The study revealed specific benefits of RIRS compared to mPCNL regarding hospital duration and complication rates [21]. In another study on bigger renal stones (2–4 cm), Lai et al. [22]. compared RIRS with vacuum-assisted UAS (V-UAS) and mPCNL. The duration of surgery was significantly longer in RIRS patients than in individuals operated on via mPCNL. Despite the mPCNL group exhibiting a markedly higher beginning SFR (73.2% vs. 50%, P = 0.035), the ultimate SFR was similar between the RIRS and mPCNL groups (89.3% vs. 92.9%, P = 0.681) [22]. Those two studies were excluded as the sizes of the stones were larger than those included in the trials in our review.
Rodrigues et al. [23] conducted a retrospective analysis to compare mPCNL (n = 21) and RIRS (n = 42) for stones measuring up to 1550 mm³. The patients were monitored using computed tomography during the postoperative period. The SFRs were comparable among the groups (76.2% vs. 66.7%, p = 0.42, and 90.5% vs. 85.7%, p = 0.57). The complication rate was comparable (26.1% vs. 9.6%, p = 0.188), although mPCNL resulted in prolonged hospitalization and fluoroscopy duration (p = 0.001 for both).
RIRS is inferior to PCNL in the treatment of lower pole stones. Many randomized controlled trials have consistently shown that PCNL outcomes are markedly superior. SFR was compared to RIRS for managing lower pole stones [24]. Huang et al. [25] conducted a study on therapy selection for patients with lower pole stones measuring between 1 and 2 cm. The research findings indicated that multiple criteria are essential in ascertaining the suitable treatment strategy, including the number of stones, diameter, infundibulopelvic angle, infundibular length, and infundibular width. These criteria are critical factors in determining the appropriate treatment for renal stones in the lower pole, specifically when choosing between RIRS and PCNL [25]. Although PCNL is superior to RIRS in treating lower pole stones, meta-analyses have shown that the SFRs for RIRS and PCNL are comparable, particularly for kidney stones measuring 2–3 cm [16]. These analyses have demonstrated that RIRS can attain outcomes comparable to PCNL regarding success while displaying minimal rates of intraoperative problems [26,27,28,29,30].
De Shuba et al. [31]. conducted a systematic review and meta-analysis of two randomized and eight non-randomized studies to investigate the balance, advantages, and disadvantages of PCNL and RIRS for stones < 2 cm. PCNL techniques provided a significantly higher stone-free (p < 0.00001) but also higher complication rates (p < 0.01) and a more significant postoperative decrease in hemoglobin levels (p < 0.00001). In contrast, RIRS led to a shorter hospital stay (p < 0.0001). At subgroup analysis, RIRS provided a significantly higher SFR than minimally invasive percutaneous procedures (MIPPs) (p = 0.03) but less than standard PCNL (p = 0.0002). Hospital stay was shorter for RIRS than MIPPs (p = 0.003) and standard PCNL (p = 0.003). They concluded that given the added morbidity and lower efficacy of MIPPs, RIRS should be considered standard therapy for stones < 2 cm until appropriate randomized studies are performed. Regarding the patient-centric approach and quality of life, they proposed that treatment can be tailored to the patient by balancing the advantages and disadvantages of each technique [31]. Soderberg et al. [32]. analyzed 42 trials assessing the effects of PCNL versus RIRS in 4571 randomized participants. They reported that PCNL, compared with RIRS, may improve SFRs and reduce the need for secondary interventions but probably has little or no effect on major complications. PCNL, compared with RIRS, may have little or no impact on ureteral stricture rates and may increase the length of hospital stay. We found no evidence of unplanned medical visits or participant quality of life and indicated that a case-by-case approach is recommended for patient-centric decision-making [32].
The introduction of a flexible and navigable suction access sheath (FANS) has improved the SFR. Shrestha et al. [33] collected data from 25 centers, including 394 adult patients undergoing ureteroscopy using FANS for lower pole stones (LPS). Out of 394 patients, non-LPS (group 1) comprised 268, and the rest of 126 patients had LPS (group 2). Single-stage zero fragment SFR was seen in 58.6% (group 1) vs. 54.8% (group 2) (p = 0.619). Single-stage grade A + B SFR was achieved in 96.6% vs. 98.4% in groups 1 and 2, respectively. On multivariate analysis, Thulium fiber laser use was significantly associated with higher odds of being grade A stone-free, while stone volume had lower odds. In the LPS group, only two patients needed reintervention. The highest complication grade was Clavien 2, which was seen in the 3.2% LPS group. Gauhar et al. [34]. assessed retrograde intrarenal surgery outcomes in 50 children using ClearPetra, a flexible and navigable suction ureteral access sheath (FANS-UAS). They declared that FANS-UAS is feasible and safe, with a low rate of complications and an excellent SFR in pediatric patients. Regarding those new data, using FANS-UASs for lower pole stones is effective and safe. The SFR of lower pole stones is comparable to that of non-lower pole locations, with a very low reintervention rate in both groups. The advancements in laser technologies and the introduction of FANS could provide a forward-looking perspective and enhance outcomes for pure lower pole stones [33, 34].
Limitations
This systematic review has certain limitations. A meta-analysis could not be conducted due to the heterogeneity of studies, and the lack of access to individual patient data. The included studies also varied in terms of methodology, and follow-up durations. These factors may have limited the comparability of results and the ability to generate pooled estimates.
Conclusion
The majority of studies in this systematic review indicate that the PCNL method exhibits a superior SFR, reduced operational duration, prolonged hospital stay, and increased complication rates compared to the RIRS procedure. Evaluating patient-specific factors, including stone placement and burden, is essential while determining the suitable therapeutic strategy.
Data availability
The data supporting this study’s findings are available on request from the corresponding author. As this was a systematic review, the data and sources are publicly available and not subject to privacy or ethical restrictions.
Abbreviations
- PCNL:
-
Percutaneous Nephrolithotomy
- RIRS:
-
Retrograde Intrarenal Surgery
- FURS:
-
Flexible Ureteroscopy
- SWL:
-
Shock Wave Lithotripsy
- mPCNL:
-
Mini Percutaneous Nephrolithotomy
- MIPPs:
-
Minimally Invasive Percutaneous Procedures
- SFR:
-
Stone Free Rate
References
Mavridis C, Bouchalakis A, Tsagkaraki V, Somani BK, Mamoulakis C, Tokas T. Recurrent urinary stone formers: imaging assessment and endoscopic treatment strategies: A systematic search and review. J Clin Med 13 Haziran. 2024;13(12):3461.
Arivoli K, Valicevic AN, Oerline MK, Hsi RS, Patel SR, Hollingsworth JM. vd. Preventive Pharmacological Therapy and Risk of Recurrent Urinary Stone Disease. Clin J Am Soc Nephrol. 01 Mayıs 2024;19(5):565– 72.
Tzelves L, Türk C, Skolarikos A. European association of urology urolithiasis guidelines: where are we going?? Eur Urol Focus Ocak. 2021;7(1):34–8.
Nedbal C, Somani BK. Lower pole stones 1–2 cm: navigating treatment choices. BJU Int. 11 Kasım. 2024.
Dutta R, Mithal P, Klein I, Patel M, Gutierrez-Aceves J. Outcomes and costs following Mini-percutaneous nephrolithotomy or flexible ureteroscopic lithotripsy for 1-2-cm renal stones: data from a prospective, randomized clinical trial. J Urol Haziran. 2023;209(6):1151–8.
Shabana W, Oquendo F, Hodhod A, Ahmad A, Alaref A, Trigo S. vd. Miniaturized ambulatory percutaneous nephrolithotomy versus flexible ureteroscopy in the management of lower Calyceal renal stones 10–20 mm: A propensity score matching analysis. Urol Ekim. 2021;156:65–70.
Coskun A, Eryildirim B, Sarica K, Çamur E, Can U, Saglam E. Comparison of mini percutaneous nephrolithotomy (Mini PCNL) and retrograde intrarenal surgery (RIRS) for the minimal invasive management of lower caliceal stones. Urol J 23 Şubat. 2021;18(5):485–90.
Zhang H, Hong TY, Li G, Jiang N, Hu C, Cui X. vd. Comparison of the efficacy of Ultra-Mini PCNL, flexible ureteroscopy, and shock wave lithotripsy on the treatment of 1–2 cm lower pole renal calculi. Urol Int. 2019;102(2):153–9.
Fayad AS, Elsheikh MG, Ghoneima W. Tubeless mini-percutaneous nephrolithotomy versus retrograde intrarenal surgery for lower Calyceal stones of ⩽2 cm: A prospective randomised controlled study. Arab J Urol Mart. 2017;15(1):36–41.
Bozzini G, Verze P, Arcaniolo D, Dal Piaz O, Buffi NM, Guazzoni G. vd. A prospective randomized comparison among SWL, PCNL and RIRS for lower Calyceal stones less than 2 cm: a multicenter experience: A better Understanding on the treatment options for lower pole stones. World J Urol Aralık. 2017;35(12):1967–75.
Kandemir A, Guven S, Balasar M, Sonmez MG, Taskapu H, Gurbuz R. A prospective randomized comparison of micropercutaneous nephrolithotomy (Microperc) and retrograde intrarenal surgery (RIRS) for the management of lower pole kidney stones. World J Urol Kasım. 2017;35(11):1771–6.
Jung GH, Jung JH, Ahn TS, Lee JS, Cho SY, Jeong CW. vd. Comparison of retrograde intrarenal surgery versus a single-session percutaneous nephrolithotomy for lower-pole stones with a diameter of 15 to 30 mm: A propensity score-matching study. Korean J Urol Temmuz. 2015;56(7):525–32.
Armagan A, Karatag T, Buldu I, Tosun M, Basibuyuk I, Istanbulluoglu MO. vd. Comparison of flexible ureterorenoscopy and micropercutaneous nephrolithotomy in the treatment for moderately size lower-pole stones. World J Urol Kasım. 2015;33(11):1827–31.
Koyuncu H, Yencilek F, Kalkan M, Bastug Y, Yencilek E, Ozdemir AT. Intrarenal surgery vs percutaneous nephrolithotomy in the management of lower pole stones greater than 2 cm. Int Braz J Urol. 2015;41(2):245–51.
Kirac M, Bozkurt ÖF, Tunc L, Guneri C, Unsal A, Biri H. Comparison of retrograde intrarenal surgery and mini-percutaneous nephrolithotomy in management of lower-pole renal stones with a diameter of smaller than 15 mm. Urolithiasis Haziran. 2013;41(3):241–6.
Kucukyangoz M, Gucuk A. What should the optimal access site be for percutaneous treatment of anterior lower pole calyx stones? World J Urol 20 Mart. 2024;42(1):176.
Akram M, Jahrreiss V, Skolarikos A, Geraghty R, Tzelves L, Emilliani E. vd. Urological Guidelines for Kidney Stones: Overview and Comprehensive Update. J Clin Med. 16 Şubat 2024;13(4):1114.
Elmansy H, Fathy M, Hodhod A, Alaref A, Hadi RA, Abbas L. vd. Mini-percutaneous nephrolithotomy vs flexible ureteroscopy for 1–2 cm lower pole renal stones: a randomised controlled trial. BJU Int. 22 Ekim 2024.
Jiang K, Zhang P, Xu B, Luo G, Hu J, Zhu J. vd. Percutaneous nephrolithotomy vs. Retrograde intrarenal surgery for renal stones larger than 2 cm in patients with a solitary kidney: A systematic review and a Meta-Analysis. Urol J 28 Temmuz. 2020;17(5):442–8.
Perri D, Berti L, Pacchetti A, Morini E, Maltagliati M, Besana U. vd. A comparison among RIRS and miniperc for renal stones between 10 and 20 mm using thulium fiber laser (Fiber Dust): a randomized controlled trial. World J Urol Ekim. 2022;40(10):2555–60.
Lv G, Wang K, Zhang Z, Zhou C, Li Y, Zhang D. Comparison of flexible ureteroscopy and mini-percutaneous nephrolithotomy in the treatment for renal calculi larger than 2 cm: a matched-pair analysis. Urolithiasis Ağustos. 2022;50(4):501–7.
Lai D, He Y, Li X, Chen M, Zeng X. RIRS with Vacuum-Assisted ureteral access sheath versus MPCNL for the treatment of 2–4 cm renal stone. Biomed Res Int. 2020;2020:8052013.
Rodrigues JECM, Vicentini FC, Danilovic A, Marchini GS, Torricelli FCM, Batagello CA. vd. Comparison of the outcomes of flexible ureteroscopy and mini-percutaneous nephrolithotomy for the treatment of kidney stones: a matched-pair analysis. Rev Assoc Med Bras (1992). 2022;68(10):1481-5.
Tonyali S, Haberal HB, Esperto F, Hamid Z, Tzelves L, Pietropaolo A. vd. The prime time for flexible ureteroscopy for large renal stones is coming: is percutaneous nephrolithotomy no longer needed?? Urol Res Pract Eylül. 2023;49(5):280–4.
Huang Y, Li K, Yang W, Li Z, Liu C, Lai C. vd. A scoring system for optimal selection of endoscopic treatment for 1-2 cm lower pole renal calculi. Urol J 08 Kasım. 2022;19(5):356–62.
Qi Y, Xing H, Yang S, Peng Z, Chen Y, Qi S. Antegrade flexible ureteroscopy-assisted percutaneous nephrolithotomy for Staghorn calculi: a prospective randomized controlled study. Urolithiasis 10 Şubat. 2024;52(1):33.
He Q, Huang Q, Hou B, Hao Z. Prediction of percutaneous nephrolithotomy outcomes and flexible ureteroscopy outcomes using nephrolithometry scoring systems. Int Urol Nephrol Mayıs. 2024;56(5):1585–93.
Chen Y, Xi H, Yu Y, Cheng X, Yang H, Deng W. vd. Flexible ureteroscopy with novel flexible ureteral access sheath versus mini-percutaneous nephrolithotomy for treatment of 2–3 cm renal stones. Int J Urol Mart. 2024;31(3):281–6.
Tian C, Qiao J, An L, Hong Y, Xu Q, Xiong L. vd. Risk factors and prediction model for postoperative complications in patients with struvite stones after percutaneous nephrolithotomy and flexible ureteroscopy. World J Urol. 02 Eylül 2024;42(1):501.
Wang QL, Liu JQ, Cao J, Ding J. Clinical efficacy and safety of flexible ureteroscopy and percutaneous nephrolithotomy for large kidney stones: A retrospective comparative study. World J Clin Cases 26 Temmuz. 2024;12(21):4483–90.
De S, Autorino R, Kim FJ et al. Percutaneous nephrolithotomy versus retrograde intrarenal surgery: a systematic review and meta-analysis [published correction appears in Eur Urol. 2016;69(4):e85. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.eururo.2015.12.046]. Eur Urol. 2015;67(1):125–137. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.eururo.2014.07.003.
Soderberg L, Ergun O, Ding M, Parker R, Borofsky MS, Pais V, Dahm P. Percutaneous nephrolithotomy versus retrograde intrarenal surgery for treatment of renal stones in adults. Cochrane Database Syst Rev. 2023;11(11):CD013445. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/14651858.CD013445.pub2. PMID: 37955353; PMCID: PMC10642177.
Shrestha A, Traxer O, Seitz C, et al. Assessing flexible ureteroscopy outcomes for lower pole versus Non lower pole stones using the flexible and navigable Suction ureteric access sheath: a prospective multicenter study by EAU endourology and PEARLS group. World J Urol. 2024;43(1):41. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00345-024-05384-5. Published 2024 Dec 20.
Gauhar V, Madarriaga YQ, Somani B, et al. Is flexible and navigable Suction ureteral access sheath (FANS-UAS) the next best development for retrograde intrarenal surgery in children? Results of a prospective multicentre study. World J Urol. 2024;42(1):627. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00345-024-05337-y. Published 2024 Nov 6.
Funding
There is no specific funding related to this research.
Author information
Authors and Affiliations
Contributions
T.A. prepared the study concept and design. N.A and M.D obtained and analysed the data. I.O.Y contributed significantly to the creation of the new software used in the study; T.A, M.G.A and M.D drafted the manuscript.
Corresponding author
Ethics declarations
Human ethics and consent to participate declarations
Not applicable, as this systematic review did not involve direct interaction with human participants or collection of personal data
Consent to participate
Not applicable, as this study was a systematic review and did not involve direct interaction with human participants.
Consent to publish
Not applicable, as this study is a systematic review and did not include individual-level data or identifiable personal information.
Approval committee or the internal review board (IRB)
This study does not involve direct interaction with human participants and therefore did not require approval from an Institutional Review Board (IRB)
Editorial support
QA Executive Consultancy, Ozan Batigun MD, MBA in 2024, has conducted the editorial support of this article. https://www.QAexeutiveconsultancy.com
AI statement
The authors used AI and AI-assisted Technologies (Grammarly and MS Word Editor) in the writing process. These technologies improved the readability and language of the work. Still, they did not replace key authoring tasks such as producing scientific or medical insights, drawing scientific conclusions, or providing clinical recommendations. The authors are ultimately responsible and accountable for the contents of the whole work.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Ates, T., Akdogan, N., Yılmaz, I.O. et al. Percutaneous nephrolithotomy versus retrograde intrarenal surgery on mid-sized lower calyx stones– a systematic review of last decade. BMC Urol 25, 84 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12894-025-01771-1
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12894-025-01771-1